Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Knee ; 35: 114-123, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35306352

ABSTRACT

BACKGROUND: Osteoarthritis (OA) is a joint disease of multifactorial etiology, affecting mainly the knees. We aimed to evaluate the effects of two different doses of gaseous ozone intra-articularly on the knee cartilage morphology of rats with osteoarthritis (OA). METHODS: The articular lesion was induced by sodium monoiodoacetate (MIA). 40 Wistar rats were divided into 4 groups: G1 control (without lesion and without treatment), G2 articular lesion (AL) (only lesion MIA-induced), G3 AL + treatment with 5 µg/mL of ozone intra-articular, and G4 AL + treatment with 10 µg/mL of ozone intra-articular. The experiment was carried out for 60 days. RESULTS: Both doses of ozone intra-articular demonstrated less reduction in joint space (G3 and G4) compared to the G2, formation of osteophytes, but without subchondral sclerosis. Ozone decreased the volumetric density of the articular lesion (VV(AL)) of tibial. The treatments recovered VV(AL) of the femur similar to G1. Ozone lower dose (G3) showed lower tibia and femur macroscopic scores. CONCLUSION: Intra-articular gaseous ozone can delay the degeneration of articular cartilage and can represents an integrative therapy in the OA treatment of knee after 60 days of treatment. For the first time the role of ozone in articular cartilage degeneration was evaluated helping to understand this therapy.


Subject(s)
Cartilage, Articular , Osteoarthritis, Knee , Osteoarthritis , Ozone , Animals , Cartilage, Articular/pathology , Disease Models, Animal , Humans , Knee Joint/pathology , Osteoarthritis/chemically induced , Osteoarthritis/drug therapy , Osteoarthritis, Knee/chemically induced , Osteoarthritis, Knee/drug therapy , Osteoarthritis, Knee/pathology , Ozone/adverse effects , Rats , Rats, Wistar
2.
J Nutr Biochem ; 90: 108572, 2021 04.
Article in English | MEDLINE | ID: mdl-33388348

ABSTRACT

We investigated whether combined long-term fructose and prednisolone intake would be more detrimental to the glucose homeostasis than if ingested separately. We also evaluated whether fish oil administration or interruption of treatments has any positive impact. For this, male adult Wistar rats ingested fructose (20%) (F) or prednisolone (12.5 µg/mL) (P) or both (FP) through drinking water for 12 weeks. A separate group of fructose and prednisolone-treated rats received fish oil treatment (1 g/kg) in the last 6 weeks. In another group, the treatment with fructose and prednisolone was interrupted after 12 weeks, and the animals were followed for more 12 weeks. Control groups ran in parallel (C). The F group had higher plasma TG (+42%) and visceral adiposity (+63%), whereas the P group had lower insulin sensitivity (-33%) and higher insulinemia (+200%). Only the the FP group developed these alterations combined with higher circulating uric acid (+126%), hepatic triacylglycerol content (+16.2-fold), lipid peroxidation (+173%) and lower catalase activity (-32%) that were associated with lower protein kinase B content and AMP-activated protein kinase (AMPK) phosphorylation in the liver, lower AMPK phosphorylation in the adipose tissue and higher beta-cell mass. Fish oil ingestion attenuated the elevation in circulating triacylglycerol and uric acid values, while the interruption of sugar and glucocorticoid intake reverted almost all modified parameters. In conclusion, long-term intake of fructose and prednisolone by male rats are more detrimental to glucose and lipid homeostasis than if ingested separately and the benefits of treatment interruption are broader than fish oil treatment.


Subject(s)
Fish Oils/pharmacology , Fructose/pharmacology , Glucocorticoids/pharmacology , Glucose/metabolism , Lipid Metabolism , Prednisolone/pharmacology , Adipose Tissue/metabolism , Adiposity/drug effects , Animals , Fish Oils/administration & dosage , Fructose/administration & dosage , Glucocorticoids/administration & dosage , Homeostasis , Humans , Insulin/metabolism , Insulin Resistance , Lipid Peroxidation , Liver/metabolism , Male , Prednisolone/administration & dosage , Rats , Rats, Wistar , Sugar-Sweetened Beverages , Triglycerides/blood , Uric Acid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...